@prefix this: . @prefix sub: . @prefix np: . @prefix pav: . @prefix rdf: . @prefix infores: . @prefix xsd: . @prefix umls: . @prefix orcid: . @prefix rdfs: . @prefix biolink: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:ChemicalEntity; rdfs:label "LDL"; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "cholesterol"; biolink:category biolink:ChemicalEntity . a biolink:ChemicalEntity; rdfs:label "Atorvastatin"; biolink:category biolink:ChemicalEntity . umls:C0570410 a biolink:ChemicalEntity; rdfs:label "Statins", "statins"; biolink:category biolink:ChemicalEntity . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "dyslipidemia"; biolink:category biolink:DiseaseOrPhenotypicFeature . a biolink:DiseaseOrPhenotypicFeature; rdfs:label "CVD", "cardiovascular diseases"; biolink:category biolink:DiseaseOrPhenotypicFeature . sub:_1 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_2 rdf:object ; rdf:predicate biolink:associated_with; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . sub:_3 rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a biolink:Association; biolink:aggregator_knowledge_source infores:knowledge-collaboratory; biolink:category biolink:Association; biolink:publications . } sub:provenance { sub:assertion prov:generatedAtTime "2022-10-13T12:35:21.230396"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627; prov:wasQuotedFrom " Atorvastatin and other statins are considered first-line treatment options for dyslipidemia. The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels) is a significant risk factor for the development of CVD. Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a" . biolink: pav:version "2.3.0" . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB"; npx:hasSignature "F40zk/co0p7hBtTcctGxpo+87Kg8Pd7CDOQb+Tac/oMtc9OlspkxUU2hfzi4VHm7CTLhhz2Ag0EcNNbVUKwvDCDOZtLvZWXNQkF/SoNQR9vQkaShAOmVndQtccuOzE/NugmJXRIqKxbYjajt9QSDNx3mdoO/lb9vMZBU/WTx+DaeFJnTxa6DfUAdCGsif/TIRu3QQtaQBaZhYWHRgFiUYLlzgTqi/eQdcjDF06zk1r1PJ3N42+Bpetsk6Ji5xJFh122slp+ZhEr3MAOJz+ddQtQpAt63QtXBjBSaz9upcWz33C8o7MK73uvt1uJ0BZV5t519NVzy/UPOGbpjN7afjg=="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2022-10-13T12:35:21.230396"^^xsd:dateTime; prov:wasAttributedTo orcid:0000-0002-3668-2627 . }